News | November 09, 2009

New Technology From Prescient Medical Featured at Canaccord Adams Cardiovascular Conference

November 9, 2009 — Two products from Prescient Medical, the vProtect Luminal Shield and the vPredict Optical Catheter System, will be featured at the third annual Canaccord Adams Cardiovascular Conference.

The conference will take place on Tuesday, Nov. 10 in San Francisco, and will bring together a select group of med-tech and biotech companies focused on the most important markets in cardiovascular medicine. Prescient Medical is one of only 15 development-stage private companies invited to present to potential investors at the conference.

The vProtect Luminal Shield is a novel self-expanding coronary stent system that received CE mark certification in August for use in improving coronary artery luminal diameter in patients with symptomatic ischemic heart disease. The Shield also was recently honored with Frost & Sullivan's 2009 North American Product Innovation of the Year Award. Designed specifically to minimize arterial injury and its consequences, the Shield is ideal for treating softer plaques, including plaques in patients who have recently suffered a heart attack and so-called vulnerable plaques.

Vulnerable plaques are prone to rupture, causing a release of cholesterol and cellular debris into the blood stream that often results in a clot that obstructs blood flow to the heart, thus causing a heart attack.
The vPredict Optical Catheter System is being developed for the detection and characterization of vulnerable plaque. The vPredict Optical Catheter System platform is based on Raman spectroscopy, a highly sensitive technology that is used in scores of critical non-clinical applications. The vPredict Optical Catheter System detects the clinically important compounds, including cholesterols, in the vessel wall and plaque.

"We are pleased to have our products featured at the Canaccord Adams Cardiovascular Conference," said Prescient CEO Patricia Scheller. "We believe our products have the potential to revolutionize the practice of interventional cardiology by enabling physicians to better treat and ultimately to prevent heart attacks."

For more information:

Related Content

NIRS-IVUS Detects Patients and Plaques Vulnerable to Subsequent Adverse Coronary Events
News | Intravascular Imaging | September 25, 2018
September 25, 2018 – New data demonstrate the correlation between the presence of non-flow-limiting, non-intervened-u
Infraredx Announces Japanese Launch of Makoto Intravascular Imaging System and Dualpro IVUS+NIRS Catheter
News | Intravascular Imaging | August 10, 2018
Infraredx Inc. announced the Makoto Intravascular Imaging System, and accompanying Dualpro intravascular ultrasound and...
Technology | Intravascular Imaging | May 02, 2018
May 2, 2018 — Conavi Medical Inc. has received 510(k) clearance from the U.S.
Videos | Intravascular Imaging | March 27, 2018
A discussion with Ron Waksman, M.D., associate director of the division of cardiology and director of cardiovascular
Avinger, Lightbox L250 imaging console, upgrade, Lumivascular platform, OCT, optical coherence tomography
Technology | Intravascular Imaging | January 11, 2017
January 11, 2017 — Avinger Inc. recently announced the U.S.
IVPA, intravascular photoacoustic imaging, fatty arteries, Purdue, Shanghai

IVPA/IVUS imaging of a perfused fresh human right coronary artery dissected from an explanted heart. (A) IVPA image. (B) IVUS image. (C) Merged IVPA/IVUS image. The 1 mm scale bar applies to all panels.

News | Intravascular Imaging | May 25, 2016
A new imaging system known as intravascular photoacoustic (IVPA) imaging that produces three-dimensional images of the...
PCI, OFDI, OCT, optical coherence tomography, optimal frequency domain imaging, EuroPCR 2016 study
News | Intravascular Imaging | May 20, 2016
Using optimal frequency domain imaging (OFDI) to guide percutaneous coronary intervention (PCI) with second-generation...
vulnerable plaques, OCT, IVUS, catheter, combination, NIBIB study

The dual catheter OCT-IVUS imaging device can be inserted into an artery to simultaneously capture an infrared image of the arterial wall (OCT, at left) and an ultrasound image (IVUS, right) that doctors use to determine the potential that a plaque is susceptible to rupture that could cause a heart attack or stroke.

News | Intravascular Imaging | May 12, 2016
May 12, 2016 — Collaboration between two National Institute of Biomedical Imaging and Bioengineering (NIBIB)-funded l
St. Jude Medical, Optis Mobile Sytem, Europe and Japan launch, OCT and angiography
Technology | Intravascular Imaging | February 08, 2016
St. Jude Medical Inc. announced the launch of the company’s Optis Mobile System in Japan and Europe. The diagnostic...
Overlay Init